113 related articles for article (PubMed ID: 32234828)
1. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
3. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
4. Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers.
Verploegh ISC; Conidi A; Brouwer RWW; Balcioglu HE; Karras P; Makhzami S; Korporaal A; Marine JC; Lamfers M; Van IJcken WFJ; Leenstra S; Huylebroeck D
Neuro Oncol; 2022 Dec; 24(12):2133-2145. PubMed ID: 35639831
[TBL] [Abstract][Full Text] [Related]
5. DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells.
Chen B; McCuaig-Walton D; Tan S; Montgomery AP; Day BW; Kassiou M; Munoz L; Recasens A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924599
[TBL] [Abstract][Full Text] [Related]
6. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
Zhao X; Sun Q; Dou C; Chen Q; Liu B
Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
[TBL] [Abstract][Full Text] [Related]
7. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
[TBL] [Abstract][Full Text] [Related]
8. Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.
Xu Z; Zeng X; Xu J; Xu D; Li J; Jin H; Jiang G; Han X; Huang C
Neuro Oncol; 2016 Jun; 18(6):830-9. PubMed ID: 26681767
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic analysis reveals that BMP4 sensitizes glioblastoma tumor-initiating cells to mechanical cues.
Hughes JH; Ewy JM; Chen J; Wong SY; Tharp KM; Stahl A; Kumar S
Matrix Biol; 2020 Jan; 85-86():112-127. PubMed ID: 31189077
[TBL] [Abstract][Full Text] [Related]
10. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
[TBL] [Abstract][Full Text] [Related]
11. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
12. Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation.
Berezovsky AD; Poisson LM; Cherba D; Webb CP; Transou AD; Lemke NW; Hong X; Hasselbach LA; Irtenkauf SM; Mikkelsen T; deCarvalho AC
Neoplasia; 2014 Mar; 16(3):193-206, 206.e19-25. PubMed ID: 24726753
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
14. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
15. Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes.
Rodriguez-Martinez A; Alarmo EL; Saarinen L; Ketolainen J; Nousiainen K; Hautaniemi S; Kallioniemi A
BMC Med Genomics; 2011 Nov; 4():80. PubMed ID: 22118688
[TBL] [Abstract][Full Text] [Related]
16. BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma.
Liu B; Chen Q; Tian D; Wu L; Dong H; Wang J; Ji B; Zhu X; Cai Q; Wang L; Zhang S
Brain Res; 2013 Apr; 1507():115-24. PubMed ID: 23466456
[TBL] [Abstract][Full Text] [Related]
17. SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
Guo M; Goudarzi KM; Abedi S; Pieber M; Sjöberg E; Behnan J; Zhang XM; Harris RA; Bartek J; Lindström MS; Nistér M; Hägerstrand D
Oncogene; 2021 Aug; 40(32):5066-5080. PubMed ID: 34021259
[TBL] [Abstract][Full Text] [Related]
18. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile.
Hägerstrand D; He X; Bradic Lindh M; Hoefs S; Hesselager G; Ostman A; Nistér M
Neuro Oncol; 2011 Nov; 13(11):1178-91. PubMed ID: 21940738
[TBL] [Abstract][Full Text] [Related]
19. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.
Cox JL; Wilder PJ; Desler M; Rizzino A
PLoS One; 2012; 7(8):e44087. PubMed ID: 22937156
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Automated Single-Cell Imaging Analysis Reveals Dynamics of Glioblastoma Stem Cell Population During State Transition.
Chumakova AP; Hitomi M; Sulman EP; Lathia JD
Cytometry A; 2019 Mar; 95(3):290-301. PubMed ID: 30729665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
